Familial melanoma and its management

2003 ◽  
pp. 377-384
Keyword(s):  
1979 ◽  
Vol 63 (1) ◽  
pp. 145 ◽  
Author(s):  
Errikos Constant ◽  
R. R. Reimer

2009 ◽  
Vol 61 (4) ◽  
pp. 677.e1-677.e14 ◽  
Author(s):  
Sancy A. Leachman ◽  
John Carucci ◽  
Wendy Kohlmann ◽  
Kimberly C. Banks ◽  
Maryam M. Asgari ◽  
...  

1994 ◽  
Vol 59 (6) ◽  
pp. 771-775 ◽  
Author(s):  
Graeme J. Walker ◽  
Derek J. Nancarrow ◽  
Marilyn K. Walters ◽  
Jane M. Palmer ◽  
James L. Weber ◽  
...  

2019 ◽  
Vol 155 (5) ◽  
pp. 604 ◽  
Author(s):  
Kim Wong ◽  
Carla Daniela Robles-Espinoza ◽  
David Rodriguez ◽  
Saskia S. Rudat ◽  
Susana Puig ◽  
...  

2015 ◽  
Vol 15 (1) ◽  
pp. 139-144 ◽  
Author(s):  
Mark Harland ◽  
Mia Petljak ◽  
Carla Daniela Robles-Espinoza ◽  
Zhihao Ding ◽  
Nelleke A. Gruis ◽  
...  

2019 ◽  
Vol 57 (3) ◽  
pp. 203-210 ◽  
Author(s):  
Eirini Christodoulou ◽  
Remco van Doorn ◽  
Mijke Visser ◽  
Amina Teunisse ◽  
Mieke Versluis ◽  
...  

BackgroundA proportion of patients diagnosed with cutaneous melanoma reports a positive family history. Inherited variants in CDKN2A and several other genes have been shown to predispose to melanoma; however, the genetic basis of familial melanoma remains unknown in most cases. The objective of this study was to provide insight into the genetic basis of familial melanoma.MethodsIn order to identify novel melanoma susceptibility genes, whole exome sequencing (WES) analysis was applied in a Dutch family with melanoma. The causality of a candidate variant was characterised by performing cosegregation analysis in five affected family members using patient-derived tissues and digital droplet PCR analysis to accurately quantify mutant allele frequency. Functional in-vitro studies were performed to assess the pathogenicity of the candidate variant.ResultsApplication of WES identified a rare, nonsense variant in the NEK11 gene (c.1120C>T, p.Arg374Ter), cosegregating in all five affected members of a Dutch family. NEK11 (NIMA-related Kinase 11) is involved in the DNA damage response, enforcing the G2/M cell cycle checkpoint. In a melanoma from a variant carrier, somatic loss of the wildtype allele of this putative tumour suppressor gene was demonstrated. Functional analyses showed that the NEK11 p.Arg374Ter mutation results in strongly reduced expression of the truncated protein caused by proteasomal degradation.ConclusionThe NEK11 p.Arg374Ter variant identified in this family leads to loss-of-function through protein instability. Collectively, these findings support NEK11 as a melanoma susceptibility gene.


Sign in / Sign up

Export Citation Format

Share Document